ArticleBMC cancer2020

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.

Wei-Ren Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.